Roivant Sciences Ltd. (ROIV) Financials

ROIV Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 5.7 billion 435.6 million
Dec. 31, 2025 5.2 billion 251.1 million
Sept. 30, 2025 5.1 billion 257.1 million
June 30, 2025 5.0 billion 216.7 million

ROIV Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -165.1 million 77.2 million
Dec. 31, 2025 -191.5 million 105.0 million
Sept. 30, 2025 -193.5 million 81.8 million
June 30, 2025 -208.4 million 82.2 million

ROIV Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 355.7 million
Dec. 31, 2025 -313.7 million
Sept. 30, 2025 -113.5 million
June 30, 2025 -273.9 million

ROIV Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 4.3 billion - 96.3 million
Dec. 31, 2025 4.5 billion 98.5 million 98.5 million
Sept. 30, 2025 4.4 billion - 98.8 million
June 30, 2025 4.5 billion - 99.7 million

ROIV Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 812.3 million
Dec. 31, 2025 696.9 million
Sept. 30, 2025 680.9 million
June 30, 2025 680.3 million

ROIV Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 1.3 million 198.9 million 158.3 million -
Dec. 31, 2025 4.9 million 165.4 million 175.1 million -
Sept. 30, 2025 7.8 million 164.6 million 143.1 million -
June 30, 2025 4.0 million 152.9 million 134.0 million -

ROIV Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 2.5 million 320000
Dec. 31, 2025 2.0 million 700000
Sept. 30, 2025 1.6 million 111000
June 30, 2025 2.2 million 154000

ROIV Revenue by Segment
Graph available only for paid members. Upgrade to see it.

ROIV

Price: $29.53

52 week price:
10.58
32.79

Earnings Per Share: -0.54 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United Kingdom

Volume: 1.4 million

Market Capitalization: 21.4 billion

Links: